[1]
|
Reya, T., Morrison, S.J., Clarke, M.F. and Weissman, I.L. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111. doi:10.1038/35102167
|
[2]
|
Cancer statistics (Epub ahead of print) (2012).
|
[3]
|
M.D. Anderson Cancer Center (2010) Decitabine and peripheral stem cell transplantation in treating patients who have relapsed following bone marrow transplantation for leukemia, myelodysplastic syndrome, or chronic myelogenous leukemia.
http://clinicaltrials.gov/ct2/show/NCT00002832
|
[4]
|
St. Jude Children’s Research Hospital (2009) Haploidentical stem cell transplant for patients with sickle cell disease and prior stroke or abnormal transcranial ultrasound. http://clinicaltrials.gov/ct2/show/NCT00152113
|
[5]
|
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (2012) Donor peripheral blood stem cell transplant in treating patients with hematologic malignancies.
http://clinicaltrials.gov/ct2/show/NCT01028716
|
[6]
|
M.D. Anderson Cancer Center (2011) Non-myeloablative allogeneic stem cell transplantation.
http://clinicaltrials.gov/ct2/show/NCT00525876
|
[7]
|
Efebera, Y.A., Qureshi, S.R. and Khouri, I.F. (2010) Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma. Biology of Blood and Marrow Transplantation, 16, 1122-1129.
doi:10.1016/j.bbmt.2010.02.015
|
[8]
|
Fred Hutchinson Cancer Research Center (2011) Busulfan and etoposide followed by peripheral blood stem cell transplant and low-dose aldesleukin in treating patients with acute myeloid leukemia.
http://clinicaltrials.gov/ct2/show/NCT00003875
|
[9]
|
Emory University (2011) Combination high dose melphalan and autologous peripheral blood stem cell (PBSC) transplant with bortezomib for multiple myeloma: A dose and schedule finding study.
http://clinicaltrials.gov/ct2/show/NCT00793650
|
[10]
|
University of Bologna (2006) Autologous transplantation for multiple myeloma.
http://clinicaltrials.gov/ct2/show/NCT00378222
|
[11]
|
Fudan University (2012) IGEV followed by autologous transplantation for refractory or relapsed hodgkin lymphoma. http://clinicaltrials.gov/ct2/show/NCT01333605
|
[12]
|
American Heart Association (2008)
http://www.americanheart.org
|
[13]
|
National Heart Institute, Mexico (2008) Intracoronary autologous stem cell transplantation in ST elevation myocardial infarction: Tracia study.
http://clinicaltrials.gov/ct2/show/NCT00725738
|
[14]
|
Meshalkin Research Institute of Pathology of Circulation (2012) “Estimation study” for endocardial mesenchymal stem cells implantation in patients after acute myocardial infarction.
http://clinicaltrials.gov/ct2/show/NCT01394432
|
[15]
|
Barts & The London NHS Trust (2011) Bone marrow derived adult stem cells for acute anterior myocardial infarction (REGEN-AMI).
http://clinicaltrials.gov/ct2/show/NCT00765453
|
[16]
|
University of Zurich (2008) Swiss multicenter intracoronary stem cells study in acute myocardial infarction (SWISS-AMI). http://clinicaltrials.gov/ct2/show/NCT00355186
|
[17]
|
Kyoto Prefectural University of Medicine (2011) Autologous human cardiac-derived stem cell to treat ischemic cardiomyopathy (ALCADIA).
http://clinicaltrials.gov/ct2/show/NCT00981006
|
[18]
|
Shanghai Jiao Tong University, School of Medicine (2012) Autologous hematopoietic stem cell transplantation for early onset type 1 diabetes.
http://clinicaltrials.gov/ct2/show/NCT00807651
|
[19]
|
Zhang., X.F., Ye, L. and Hu, J. (2012) Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1diabetic patient. PLOS One, 7, e31887. doi:10.1371/journal.pone.0031887
|
[20]
|
Boston Medical Center (2012) Bortezomib and dexamethasone followed by high-dose melphalan and stem cell transplantation for primary (AL) amyloidosis.
http://clinicaltrials.gov/ct2/show/NCT01083316
|
[21]
|
Stanford University (2010) Autologous stem cell rescue for primary amyloidosis.
http://clinicaltrials.gov/ct2/show/NCT00186407
|
[22]
|
Adistem Ltd. (2008) Safety and efficacy of autologous adipose-derived stem cell transplantation in type 2 diabetics. http://clinicaltrials.gov/ct2/show/NCT00703612
|
[23]
|
Cellonis Biotechnology Co. Ltd. (2010) Stem cell therapy for type 2 diabetes mellitus.
http://clinicaltrials.gov/ct2/show/NCT01142050
|
[24]
|
Postgraduate Institute of Medical Education and Research (2008) Efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus (SCT).
http://clinicaltrials.gov/ct2/show/NCT00644241
|
[25]
|
Marmont, A.M., van Lint, M.T., Gualandi, F. and Bacigalupo, A. (1997) Autologous marrow mstem cell transplantation for systemic lupus erythematosus of long duration. Lupus, 6, 545-548.
doi:10.1177/096120339700600613
|
[26]
|
Fairview University Medical Center (2005) Autologous peripheral blood stem cell transplantation in patients with life threatening autoimmune diseases.
http://clinicaltrials.gov/ct2/show/NCT00006055
|
[27]
|
National Cancer Institute (NCI) (2012) Lymphocyte depletion and stem cell transplantation to treat severe systemic lupus erythematosus.
http://clinicaltrials.gov/ct2/show/NCT00076752
|
[28]
|
Charite University (2011) Autologous stem cell transplantation for refractory systemic lupus erythematosus (ASSIST). http://clinicaltrials.gov/ct2/show/NCT00750971
|
[29]
|
Burt, R. (2012) Allogeneic stem cell transplantation in systemic lupus erythematosus.
http://clinicaltrials.gov/ct2/show/NCT00278590
|
[30]
|
National Heart, Lung, and Blood Institute (NHLBI) (2009) Allogeneic blood stem cell transplantation for patients with life-threatening systemic lupus erythematosus.
http://clinicaltrials.gov/ct2/show/NCT00325741
|
[31]
|
St. Jude Children’s Research Hospital (2009) Transplantation of hematopoietic cells in children with severe combined immunodeficiency syndrome.
http://clinicaltrials.gov/ct2/show/NCT00152100
|
[32]
|
National Human Genome Research Institute (NHGRI) (2012) Gene transfer therapy for severe combined immunodeficieny disease (SCID) due to adenosine deaminase (ADA) deficiency.
http://clinicaltrials.gov/show/NCT00018018
|
[33]
|
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. A Cancer Journal for Clinicians, 61, 69-90.
|
[34]
|
H. Lee (2009) Combination chemotherapy followed by peripheral stem cell transplantation in treating women with metastatic breast cancer.
http://clinicaltrials.gov/ct2/show/NCT00006032
|
[35]
|
Robert H. and Lurie Cancer Center (2009) Combination chemotherapy and peripheral stem cell transplantation in treating women with metastatic breast cancer.
http://clinicaltrials.gov/ct2/show/NCT00004906
|
[36]
|
Northwestern University (2011) Chemotherapy, filgrastim, and stem cell transplantation with radiation therapy in treating patients with stage III or stage IV breast cancer.
http://clinicaltrials.gov/show/NCT00004172
|
[37]
|
www.medicinenet.com
|